Vitrafy Life Sciences's Cryopreservation Ecosystem Used In USAISR's Phase Two Platelet Cryopreservation Study, Shares Rise 5%

MT Newswires Live

04/08

Vitrafy Life Sciences (ASX:VFY) said the US Army Institute of Surgical Research (USAISR) completed the phase two testing of its platelet cryopreservation study using Vitrafy's cryopreservation ecosystem, according to a Wednesday Australian bourse filing.

The study sought to confirm the consistency of earlier results and further characterise performance across multiple cryopreservation formulations. The work was carried out under the ongoing cooperative research and development agreement (CRADA) between the firm and the US Army.

Its shares rose 5% in recent trading on Wednesday.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2625996561"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2625996561\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2625996561?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-08 10:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2625996561","market":"us","top_or_hot":-1,"title":"Vitrafy Life Sciences's Cryopreservation Ecosystem Used In USAISR's Phase Two Platelet Cryopreservation Study, Shares Rise 5%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/VFY.AU\">Vitrafy Life</a> Sciences (ASX:VFY) said the US Army Institute of Surgical Research (USAISR) completed the phase two testing of its platelet cryopreservation study using Vitrafy's cryopreservation ecosystem, according to a Wednesday Australian bourse filing.</p><p>The study sought to confirm the consistency of earlier results and further characterise performance across multiple cryopreservation formulations. The work was carried out under the ongoing cooperative research and development agreement (CRADA) between the firm and the US Army.</p><p>Its shares rose 5% in recent trading on Wednesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vitrafy Life Sciences's Cryopreservation Ecosystem Used In USAISR's Phase Two Platelet Cryopreservation Study, Shares Rise 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVitrafy Life Sciences's Cryopreservation Ecosystem Used In USAISR's Phase Two Platelet Cryopreservation Study, Shares Rise 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-04-08 10:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/VFY.AU\">Vitrafy Life</a> Sciences (ASX:VFY) said the US Army Institute of Surgical Research (USAISR) completed the phase two testing of its platelet cryopreservation study using Vitrafy's cryopreservation ecosystem, according to a Wednesday Australian bourse filing.</p><p>The study sought to confirm the consistency of earlier results and further characterise performance across multiple cryopreservation formulations. The work was carried out under the ongoing cooperative research and development agreement (CRADA) between the firm and the US Army.</p><p>Its shares rose 5% in recent trading on Wednesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7048","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2625996561","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2625996561","pubTimestamp":1775616251,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Vitrafy Life Sciences  said the US Army Institute of Surgical Research  completed the phase two testing of its platelet cryopreservation study using Vitrafy's cryopreservation ecosystem, according to a Wednesday Australian bourse filing.The study sought to confirm the consistency of earlier results and further characterise performance across multiple cryopreservation formulations. The work was carried out under the ongoing cooperative research and development agreement  between the firm and the US Army.Its shares rose 5% in recent trading on Wednesday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7048":"生命科学工具和服务","VFY.AU":"Vitrafy Life Sciences Ltd"},"translate_title":"Vitrafy Life Sciences的冷冻保存生态系统用于USAISR二期血小板冷冻保存研究，股价上涨5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VFY.AU":1},"content_text":"Vitrafy Life Sciences (ASX:VFY) said the US Army Institute of Surgical Research (USAISR) completed the phase two testing of its platelet cryopreservation study using Vitrafy's cryopreservation ecosystem, according to a Wednesday Australian bourse filing.The study sought to confirm the consistency of earlier results and further characterise performance across multiple cryopreservation formulations. The work was carried out under the ongoing cooperative research and development agreement (CRADA) between the firm and the US Army.Its shares rose 5% in recent trading on Wednesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}